Personalized medicine in psychiatry: problems and promises

被引:173
|
作者
Ozomaro, Uzoezi [1 ]
Wahlestedt, Claes [1 ,2 ,3 ]
Nemeroff, Charles B. [1 ,2 ,3 ]
机构
[1] Univ Miami, Leonard M Miller Sch Med, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Ctr Therapeut Innovat, Miami, FL 33136 USA
[3] Univ Miami, Leonard M Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL USA
来源
BMC MEDICINE | 2013年 / 11卷
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
Major depressive disorder; Schizophrenia; Personalized medicine; Psychiatric hereditability; Epigenetics; Environmental factors; Endophenotypes; Pharmacogenomics; Neuroimaging genetics; CORTICOTROPIN-RELEASING-FACTOR; SEROTONIN TRANSPORTER GENE; GENOME-WIDE ASSOCIATION; INDUCED WEIGHT-GAIN; SINGLE NUCLEOTIDE POLYMORPHISM; MAJOR DEPRESSIVE DISORDER; FAMILY-BASED ASSOCIATION; 5-HT2A RECEPTOR GENE; CLOZAPINE-INDUCED AGRANULOCYTOSIS; ABNORMAL INVOLUNTARY MOVEMENTS;
D O I
10.1186/1741-7015-11-132
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The central theme of personalized medicine is the premise that an individual's unique physiologic characteristics play a significant role in both disease vulnerability and in response to specific therapies. The major goals of personalized medicine are therefore to predict an individual's susceptibility to developing an illness, achieve accurate diagnosis, and optimize the most efficient and favorable response to treatment. The goal of achieving personalized medicine in psychiatry is a laudable one, because its attainment should be associated with a marked reduction in morbidity and mortality. In this review, we summarize an illustrative selection of studies that are laying the foundation towards personalizing medicine in major depressive disorder, bipolar disorder, and schizophrenia. In addition, we present emerging applications that are likely to advance personalized medicine in psychiatry, with an emphasis on novel biomarkers and neuroimaging.
引用
收藏
页数:35
相关论文
共 50 条
  • [1] Personalized medicine in psychiatry: problems and promises
    Uzoezi Ozomaro
    Claes Wahlestedt
    Charles B Nemeroff
    BMC Medicine, 11
  • [2] Personalized medicine in psychiatry
    Wium-Andersen, Ida Kim
    Vinberg, Maj
    Kessing, Lars Vedel
    McIntyre, Roger S.
    NORDIC JOURNAL OF PSYCHIATRY, 2017, 71 (01) : 12 - 19
  • [3] The promises of personalized medicine
    Cascorbi, Ingolf
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (08) : 749 - 754
  • [4] The promises of personalized medicine
    Ingolf Cascorbi
    European Journal of Clinical Pharmacology, 2010, 66 : 749 - 754
  • [5] Genetics in psychiatry: Are the promises met?
    Bondy, Brigitta
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2011, 12 (02) : 81 - 88
  • [6] Personalized Medicine in Systemic Sclerosis: Facts and Promises
    Dobrota, Rucsandra
    Mihai, Carina
    Distler, Oliver
    CURRENT RHEUMATOLOGY REPORTS, 2014, 16 (06)
  • [7] Personalized Medicine and Mood Disorders
    Alhajji, Lujain
    Nemeroff, Charles B.
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 2015, 38 (03) : 395 - +
  • [8] Foundations, promises and uncertainties of personalized medicine
    Bottinger, Erwin P.
    MOUNT SINAI JOURNAL OF MEDICINE, 2007, 74 (01): : 15 - 21
  • [9] Pharmacogenomics in the treatment of mood disorders: Strategies and Opportunities for personalized psychiatry
    Amare, Azmeraw T.
    Schubert, Klaus Oliver
    Baune, Bernhard T.
    EPMA JOURNAL, 2017, 8 (03) : 211 - 227
  • [10] Personalized Medicine in Systemic Sclerosis: Facts and Promises
    Rucsandra Dobrota
    Carina Mihai
    Oliver Distler
    Current Rheumatology Reports, 2014, 16